Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Hammer

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudinePaul M Coplan, John R Cook, George W Carides, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapyAshraf Coovadia, Gillian Hunt, Elaine J Abrams, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2009
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected womenMichael T Yin, Don J McMahon, David C Ferris, et al.
Science (New York, N.Y.)|July 26, 2008
HIV vaccine research: the way forwardAnthony S Fauci, Margaret I Johnston, Carl W Dieffenbach, et al.
AIDS (London, England)|February 9, 2002
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patientsJudith Falloon, Mounir Ait-Khaled, Deborah A Thomas, et al.
Sexually Transmitted Diseases|February 11, 2010
Acceptability of male circumcision for the prevention of HIV among high-risk heterosexual men in ThailandHong-Van Tieu, Nittaya Phanuphak, Jintanat Ananworanich, et al.
Antiviral Therapy|February 6, 2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavirScott M Hammer, Roland Bassett, Kathleen E Squires, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 24, 2003
Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2004
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individualsEdward P Acosta, Hulin Wu, Scott M Hammer, et al.
HIV Clinical Trials|January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimenScott M Hammer, Heather Ribaudo, Roland Bassett, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudinePaul M Coplan, John R Cook, George W Carides, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapyAshraf Coovadia, Gillian Hunt, Elaine J Abrams, et al.
The Journal of Clinical Endocrinology and Metabolism|December 8, 2009
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected womenMichael T Yin, Don J McMahon, David C Ferris, et al.
Science (New York, N.Y.)|July 26, 2008
HIV vaccine research: the way forwardAnthony S Fauci, Margaret I Johnston, Carl W Dieffenbach, et al.
AIDS (London, England)|February 9, 2002
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patientsJudith Falloon, Mounir Ait-Khaled, Deborah A Thomas, et al.
Sexually Transmitted Diseases|February 11, 2010
Acceptability of male circumcision for the prevention of HIV among high-risk heterosexual men in ThailandHong-Van Tieu, Nittaya Phanuphak, Jintanat Ananworanich, et al.
Antiviral Therapy|February 6, 2004
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavirScott M Hammer, Roland Bassett, Kathleen E Squires, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|July 24, 2003
Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines PanelMartin S Hirsch, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 16, 2004
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individualsEdward P Acosta, Hulin Wu, Scott M Hammer, et al.
HIV Clinical Trials|January 18, 2011
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimenScott M Hammer, Heather Ribaudo, Roland Bassett, et al.
Pageof 9